A new malaria antigen produces partial protection against Plasmodium yoelii challenge

Parasitology Research

Volumn 110, Issue 4, 2012, Pages 1337-1345

  Zhang, Yanhui ^a,b   Qi, Yanwei ^a   Li, Jian ^a   Liu, Shengfa ^a   Hong, Lingxian ^a   Lin, Tianlong ^c   Long, Carole ^b   Su, Xin Zhuan ^b  

^a XIAMEN UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; MALARIA VACCINE; PARASITE ANTIGEN; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN RPY01157 NT; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; BLOOD SAMPLING; DRUG SCREENING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; MALARIA; MOLECULAR CLONING; NONHUMAN; PLASMODIUM YOELII; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; BLOTTING, WESTERN; CLONING, MOLECULAR; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNIZATION; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PLASMODIUM YOELII; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, DNA;

MUS; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; RODENTIA;

EID: 84863427898     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-011-2630-y     Document Type: Article

References (23)

1. Alloueche A, Milligan P, Conway DJ, Pinder M, Bojang K, Doherty T, Tornieporth N, Cohen J, Greenwood BM (2003) Protective efficacy of the RTS, S/AS02 Plasmodium falciparum malaria vaccine is not strain specific. Am J Trop Med Hyg 68:97-101 (Pubitemid 38234855)
2. Anders RF, Adda CG, Foley M, Norton RS (2010) Recombinant protein vaccines against the asexual blood stages of Plasmodium falciparum. Hum Vaccin 6:39-53
3. Bojang KA, Milligan PJ, Pinder M, Vigneron L, Alloueche A, Kester KE, Ballou WR, Conway DJ, Reece WH, Gothard P, Yamuah L, Delchambre M, Voss G, Greenwood BM, Hill A, McAdam KP, Tornieporth N, Cohen JD, Doherty T (2001) Efficacy of RTS, S/ AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: A randomised trial. Lancet 358:1927-1934 (Pubitemid 34072872)
4. Bojang K, Milligan P, Pinder M, Doherty T, Leach A, Ofori-Anyinam O, Lievens M, Kester K, Schaecher K, Ballou WR, Cohen J (2009) Five-year safety and immunogenicity of GlaxoSmithKline's candidate malaria vaccine RTS, S/AS02 following administration to semiimmune adult men living in a malaria-endemic region of The Gambia. Hum Vaccin 5:242-247
5. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ (2009) Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361:455-467
6. Feachem RG, Phillips AA, Hwang J, Cotter C, Wielgosz B, Greenwood BM, Sabot O, Rodriguez MH, Abeyasinghe RR, Ghebreyesus TA, Snow RW (2010) Shrinking the malaria map: Progress and prospects. Lancet 376:1566-1578
7. Hoffman SL, Billingsley PF, James E, Richman A, Loyevsky M, Li T, Chakravarty S, Gunasekera A, Chattopadhyay R, Li M, Stafford R, Ahumada A, Epstein JE, Sedegah M, Reyes S, Richie TL, Lyke KE, Edelman R, Laurens MB, Plowe CV, Sim BK (2010) Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum Vaccin 6:97-106
8. Labaied M, Harupa A, Dumpit RF, Coppens I, Mikolajczak SA, Kappe SH (2007) Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection. Infect Immun 75:3758-3768 (Pubitemid 47206273)
9. Li J, Pattaradilokrat S, Zhu F, Jiang H, Liu S, Hong L, Fu Y, Koo L, Xu W, Pan W, Carlton JM, Kaneko O, Carter R, Wootton JC, Su XZ (2011) Linkage maps from multiple genetic crosses and loci linked to growth-related virulent phenotype in Plasmodium yoelii. Proc Natl Acad Sci USA 108:E374-382.
10. Lindsay GK, Roslansky PF, Novitsky TJ (1989) Single-step, chromogenic Limulus amebocyte lysate assay for endotoxin. J Clin Microbiol 27:947-951 (Pubitemid 19115667)
11. Mahajan B, Berzofsky JA, Boykins RA, Majam V, Zheng H, Chattopadhyay R, de la Vega P, Moch JK, Haynes JD, Belyakov IM, Nakhasi HL, Kumar S (2010) Multiple antigen peptide vaccines against Plasmodium falciparum malaria. Infect Immun 78:4613-4624
12. McCarthy JS, Good MF (2010) Whole parasite blood stage malaria vaccines: A convergence of evidence. Hum Vaccin 6:114-123
13. Mu J, Awadalla P, Duan J, McGee KM, Keebler J, Seydel K, McVean GA, Su X-z (2007) Genome-wide variation and identification of vaccine targets in the Plasmodium falciparum genome. Nat Genet 39:126-130 (Pubitemid 46026512)
14. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM (2008) Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 359:2619-2620
15. Pattaradilokrat S, Cheesman SJ, Carter R (2008) Congenicity and genetic polymorphism in cloned lines derived from a single isolate of a rodent malaria parasite. Mol Biochem Parasitol 157:244-247
16. Pluess B, Tanser FC, Lengeler C, Sharp BL (2010) Indoor residual spraying for preventing malaria. Cochrane Database Syst Rev CD006657
17. Polley SD, Conway DJ (2001) Strong diversifying selection on domains of the Plasmodium falciparum apical membrane antigen 1 gene. Genetics 158:1505-1512 (Pubitemid 32783136)
18. Polley SD, Chokejindachai W, Conway DJ (2003) Allele frequencybased analyses robustly map sequence sites under balancing selection in a malaria vaccine candidate antigen. Genetics 165:555-561 (Pubitemid 37337624)
19. Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, van Gemert GJ, van de Vegte-Bolmer M, van Schaijk B, Teelen K, Arens T, Spaarman L, de Mast Q, Roeffen W, Snounou G, Renia L, van der Ven A, Hermsen CC, Sauerwein R (2009) Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 361:468-477
20. Schellenberg D, Abdulla S, Roper C (2006) Current issues for antimalarial drugs to control P. falciparum malaria. Curr Mol Med 6:253-260
21. Shang Y, Song X, Bowen J, Corstanje R, Gao Y, Gaertig J, Gorovsky MA (2002) A robust inducible-repressible promoter greatly facilitates gene knockouts, conditional expression, and overexpression of homologous and heterologous genes in Tetrahymena thermophila. Proc Natl Acad Sci USA 99:3734-3739 (Pubitemid 34252175)
22. Tarun AS, Peng X, Dumpit RF, Ogata Y, Silva-Rivera H, Camargo N, Daly TM, Bergman LW, Kappe SH (2008) A combined transcriptome and proteome survey of malaria parasite liver stages. Proc Natl Acad Sci USA 105:305-310
23. WHO (2008) Accessed 01 January 2008. World Malaria Report 2008. http://www.who.int/malaria/wmr2008/malaria2008.pdf. Accessed 27 Oct 2009